Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition.
about
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the StoryAcadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell deathThe caspase 6 derived N-terminal fragment of DJ-1 promotes apoptosis via increased ROS productionCombined MEK and Pi3'-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo.Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy.A new hydroxylated nonaprenylhydroquinone from the Mediterranean marine sponge Sarcotragus spinosulus.BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients.All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to ponatinib.Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell deathRegulation of mammalian target of rapamycin and mitogen activated protein kinase pathways by BCR-ABL.Suppression of c-Myc induces apoptosis via an AMPK/mTOR-dependent pathway by 4-O-methyl-ascochlorin in leukemia cells.MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells.A non-apoptotic function of caspase-3 in pharmacologically-induced differentiation of K562 cells.Targeting lysosomes to eradicate imatinib-resistant chronic myelogenous leukemia cells.Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR-ABL cleavage and elimination of chronic myelogenous leukemia cells.Metabolic Reprogramming During Multidrug Resistance in Leukemias.
P2860
Q26742078-B63B251B-9564-4C98-99A4-681B739AC8B6Q28471941-136A0332-D6FD-4B2A-B310-B8671B21F173Q28588841-76A530B1-718F-4F47-B86F-0B79F243E881Q33648582-96B73220-9564-449B-86BD-AF2755B36B1FQ34750609-9D0640E5-9557-4037-99EC-28BFB3F56429Q35142065-9D39099E-9FCF-48D2-95A7-A1695F1A9902Q36050710-FEEAF274-AAB4-45C7-BB03-0A0C2B1BDB9EQ36926106-08769E00-4F4E-480A-A43D-A0352D0F3216Q37295598-272807A4-BDE5-4F08-9A00-9E9F57D9E84FQ37836931-5C6CEAFE-40FF-41E6-A04F-0781ED740EB5Q38790535-C6642CF4-9B0F-4401-BE25-4ACC28199E37Q39576930-3D799E4D-5F33-488B-92A5-2A85FC85445CQ39865125-D03FD56C-2411-4995-BBEA-E538A5BE0CFFQ42589038-4310CD88-98F7-431E-8CD4-43EC38F4A3B7Q43106529-E2ED2B75-B092-41A5-A6B2-2096C19597E5Q43239046-9A3F47F8-48A4-46EC-ADC3-47520AFBF027Q52575780-1FDCCFBC-E0DC-4F61-ADC2-AB335BE1A9EA
P2860
Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Apoptosis and erythroid differ ...... itivity to caspase inhibition.
@en
type
label
Apoptosis and erythroid differ ...... itivity to caspase inhibition.
@en
prefLabel
Apoptosis and erythroid differ ...... itivity to caspase inhibition.
@en
P2093
P2860
P50
P356
P1433
P1476
Apoptosis and erythroid differ ...... sitivity to caspase inhibition
@en
P2093
Belhacene N
Breittmayer JP
Colosetti P
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210034
P407
P577
2006-10-09T00:00:00Z
P5875
P6179
1005886808